化合物 RGFP 966|T1762|TargetMol

RGFP966
1357389-11-7

￥315 1mg 起订

￥453 2mg 起订

￥738 5mg 起订

上海更新日期：2024-09-29

TargetMol中国（陶术生物）

VIP3年

联系人：邵小姐

手机：4008200310 拨打

邮箱：marketing@tsbiochem.com

产品详情:

中文名称：: 化合物 RGFP 966

英文名称：: RGFP966

CAS号：: 1357389-11-7

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: 99.77%

产品类别：: 抑制剂

货号：: T1762

Product Introduction

Bioactivity

名称	RGFP966
描述	RGFP966 is an HDAC3 inhibitor (IC50: 0.08 μM) and does not affect other HDACs at concentrations up to 15 μM.
细胞实验	To investigate the influence of the HDAC 3-selective inhibitor RGFP966 on cell viability, RAW 264.7 macrophages, HBE cells and hASM cells were seeded in 96-well plates. To obtain identical cell density at the start of the experiments, RAW 264.7 macrophages were seeded at 25,000 cells/cm2, HBE cells and hASM cells were seeded at 70% confluency (based on surface area) and were serum-starved for 24 h prior incubation with RGFP966. Shortly before incubation with RGFP966, the medium was replaced by 100 μl fresh (if appropriate serum free) culture medium. Incubations with LPS and IFNγ were performed as described for HDAC 1–3 downregulation by siRNA. After 20 h of incubation with RGFP966, 20 μl of CellTiter 96 AQueous One Solution reagent was added to each well and incubated at 37 °C for 1 h in the dark. The absorbance at 490 nm was measured using a Synergy H1 plate reader. LPS/IFNγ-stimulated cells without addition of RGFP966 were considered 100% [2].
激酶实验	Briefly, the respective human recombinant HDAC enzymes were incubated in the absence and/or in presence of various concentrations RGFP966 and a pro-fluorogenic substrate at room temperature for 60 min. Next, the deacetylation reaction was stopped by the addition of the HDAC Stop Solution (6 mg/ml trypsin, 0.3 mM SAHA) in all wells and the plate was incubated at 37 °C for 20 min. The release of the fluorescent 7-amino-4-methylcoumarin was monitored by measuring the fluorescence at λem = 460 nm and λex = 390 nm using a Synergy H1 plate reader. The fluorescence value of the background wells was subtracted from the fluorescence of the positive control, blank and inhibitor wells. Nonlinear regression was used to fit the data to the log(inhibitor) vs. response curve using GraphPad Prism [2].
动物实验	Subthreshold training and a 24-h retention test for location-dependent object recognition memory (OLM) and novel object recognition memory (ORM) were performed as described previously. Mice received an injection of RGFP966 (3, 10, or 30 mg/kg s.c) or vehicle alone either 1 h before or immediately after a 3-min training seeion [1].
体外活性	RGFP966 对HDAC3具有特异性抑制作用（IC50：0.08 μM），在高至15 μM的浓度下，对其他HDAC无有效抑制 [1]。在LPS/IFNγ刺激的RAW 264.7巨噬细胞中，RGFP966处理未改变TNFα、iNOS和IL-10基因的表达，但显著降低了促炎症基因IL-1β、IL-6和IL-12b的表达 [2]。此外，RGFP966在CTCL细胞系中减缓了细胞增长，此现象与DNA损伤和S期进程受损相关的增加的细胞凋亡有关 [3]。
体内活性	所有小鼠在经过可卡因条件性位置偏好(CPP)训练后，明显偏好于与可卡因相关联的环境。在无药物偏好测试后立即使用RGFP966（3或10 mg/kg，皮下注射）治疗，在第二次和第三次后测中显著减弱了CPP。其中，10 mg/kg的剂量显著快速降低了随后几天的CPP，而3 mg/kg的剂量则没有此效果[1]。RGFP966在10和25 mg/kg的剂量下，能改善旋转木马测试和开放场探索中的运动缺陷，并伴随着对纹状体体积的神经保护作用[4]。
存储条件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	DMSO : 45 mg/mL (124.17 mM)
关键字	HDAC \| inhibit \| Histone deacetylases \| Inhibitor \| RGFP-966 \| RGFP966
相关产品	Valproic acid sodium salt \| 4-Phenylbutyric acid \| Valproic Acid \| Panobinostat \| Methyl L-histidinate dihydrochloride \| Theophylline \| Acefylline \| Curcumin \| Theophylline monohydrate \| Sodium 4-phenylbutyrate \| Vorinostat \| Parthenolide
相关库	抑制剂库 \| 抗乳腺癌化合物库 \| 经典已知活性库 \| 抗癌化合物库 \| 已知活性化合物库 \| 抗衰老化合物库 \| 高选择性抑制剂库 \| 表观遗传库 \| 癌细胞分化化合物库 \| DNA 损伤和修复分子库

RGFP 966|TargetMol

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期	(12年)
注册资本	566.265100万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,工厂,试剂,定制,服务
主营行业	天然产物,生化试剂,分子生物学,分子砌块,生物技术服务